Revance Therapeutics, Inc.

Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including our next-generation investigational neuromodulator product, DaxibotulinumtoxinA for Injection.

201-500 employees
  • Biotechnology & Chemical Products
  • Technology Infrastructure
  • Digital Payments
  • Headquarters address
    Newark